GENE ONLINE|News &
Opinion
Blog

Tulip Chakraborty

WRITTEN BY Tulip Chakraborty

Lynparza Bags Multiple Approvals in Japan
2021-01-05
Amgen and AstraZeneca’s Asthma Drug Flunks Phase 3 Trial
2020-12-26
Spotlight: Novartis’ Kisqali Shows Promising Results in Metastatic Breast Cancer
2020-12-18
CRISPR Therapeutics Scores Prestigious Grant for Advancing Gene Therapies for HIV
2020-12-16
Roche Impresses with its Bispecific Antibody Portfolio for Blood Cancer Treatments
2020-12-13
Kite Presents Yescarta’s Encouraging Long Term ZUMA-1 Trial Results at ASH2020
2020-12-06
Kinaset Therapeutics Debuts in the Asthma Market with $40 Million Financing
2020-12-02
Biogen and Sage Therapeutics Ink Deal for Treating Depression
2020-11-29
Ascentage Pharma’s Bcl-2 Inhibitor Enters Clinical Trials in Europe
2020-11-28
Oxford-AstraZeneca’s COVID-19 Vaccine Demonstrates Strong Immune Response in the Elderly
2020-11-20
Roche’s Influenza Drug Bags Recommendation for EU Approval
2020-11-15
Merck, Eisai’s Combo Therapy Registers Superiority against Pfizer’s Drug in Kidney Cancer Trial
2020-11-15
Pfizer Announces Positive Top-Line Results for JAK Inhibitor in Ankylosing Spondylitis Trial
2020-11-08
Novartis’ IL-17 Inhibitor Shines in Late-Stage Psoriatic Arthritis Trial
2020-11-06
COVID-19: CureVac Announces Promising Phase 1 Results with Lower Vaccine Dosage Than Competitors
2020-11-03
1 2 3 4 5 8
Scroll to Top